An angiotensin-converting enzyme (ACE) inhibitor called ramipril is used to treat hypertension and slow the progression of heart failure in patients, particularly those who have had a myocardial infarction in the past. In patients over 55 who are at high risk for atherosclerotic disease and severe adverse cardiac events, this medicine is also designated for lowering the risk of myocardial infarction, stroke, and death. Ramipril reduces sympathetic activity and the kidneys' ability to reabsorb water and salt by blocking the formation of angiotensin II. Blood pressure is lowered by the vasodilation that results. The indications, mechanism of action, pharmacokinetics, dosage, and administration of ramipril are reviewed in this activity. Additionally, it draws attention to important side effects, contraindications, monitoring guidelines, and drug interactions. This article encourages the treatment of cardiovascular disease and hypertension by raising doctors' awareness of these factors.